Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention.
Overview
- Department of Radiology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Department of Clinical Research and Translational Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- Department of Child Developmental Behavior, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Abstract
Background: Hypoxic-ischemic brain damage (HIBD) involves profound metabolic reprogramming, where aberrant glycolysis links to neuronal injury. This study aimed to identify and characterize glycolysis-related hub genes in HIBD.
Methods: Glycolysis-related differentially expressed genes (DEGs) were screened from the HIBD dataset GSE144456 by combining differential expression analysis, weighted gene co-expression network analysis (WGCNA), and a glycolysis gene set. Hub genes were further identified via enrichment and protein-protein interaction (PPI) network analyses and validated in an independent dataset (GSE23317) and our internal RNA-seq. The key hub gene was confirmed in a mouse HIBD model using RT-qPCR and Western blot. To perturb Hexokinase 2 (Hk2), 3-bromopyruvate (3-BrPA, 1 mg/
Results: Bioinformatics analysis identified Hk2 as a key hub gene that was consistently upregulated in HIBD. In vivo experiments demonstrated that both HK2 protein and mRNA levels were significantly elevated 24 hours after HIBD (P < 0.001). Double immunofluorescence staining further revealed that the upregulated HK2 was predominantly localized to Iba1+ microglia. Early administration of 3-BrPA reduced acute cerebral infarction volume (P < 0.001), improved neurological function scores (P < 0.001), and concurrently downregulated HK2 protein levels (P < 0.05). 3-BrPA treatment also significantly reduced lactate accumulation in the injured brain tissue (P < 0.001). It also suppressed the mRNA expression of pro-inflammatory cytokines (Tnf, Il1b, and Il6; all P < 0.001) and modulated the protein levels of inflammatory markers (iNOS, ARG1; P < 0.05 and P < 0.01, respectively). Moreover, this single early intervention significantly mitigated long-term brain tissue loss and improved motor coordination and exploratory behavior at 30 days post-injury (P < 0.05).
Conclusion: Hk2 is highlighted as a critical node associated with both glycolytic reprogramming and neuroinflammation in HIBD, with upregulation primarily in microglia. Early perturbation of glycolysis with 3-BrPA is associated with multifaceted benefits. Our findings link the Hk2-glycolysis axis to neuroinflammation, offering a rationale for exploring metabolic interventions in HIBD.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Bioinformatics data sources and pretreatment”
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 8 authors, 5 keywords, 13 MeSH terms, 1 funder, 59 references.
Cite
This paper
Li, Y., Qin, C., Miao, C., Mu, R., Zhang, P., Zhang, B., Zhao, X., & Zhang, X. (2026). Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention. Frontiers in immunology, 17, 1837728. https://
BibTeX
@article{li2026hexokinas
author = {Li, Yue and Qin, Chi and Miao, Chenxu and Mu, Ronghao and Zhang, Penghua and Zhang, Bohao and Zhao, Xin and Zhang, Xiaoan},
title = {{Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention}},
journal = {Frontiers in immunology},
year = {2026},
month = jun,
volume = {17},
pages = {1837728},
publisher = {Frontiers Media SA},
issn = {1664-3224},
doi = {10.3389/
url = {https://
pmid = {42367795},
pmcid = {PMC13303037}
}
RIS
TY - JOUR
AU - Li, Yue
AU - Qin, Chi
AU - Miao, Chenxu
AU - Mu, Ronghao
AU - Zhang, Penghua
AU - Zhang, Bohao
AU - Zhao, Xin
AU - Zhang, Xiaoan
TI - Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention
T2 - Frontiers in immunology
J2 - Front Immunol
PY - 2026
DA - 2026/
VL - 17
SP - 1837728
SN - 1664-3224
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Hexokinase 2 upregulation is associated with glycolytic reprogramming and neuroinflammation in hypoxic-ischemic brain damage: a therapeutic target for early intervention",
"container-title": "Frontiers in immunology",
"author": [
{
"family": "Li",
"given": "Yue"
},
{
"family": "Qin",
"given": "Chi"
},
{
"family": "Miao",
"given": "Chenxu"
},
{
"family": "Mu",
"given": "Ronghao"
},
{
"family": "Zhang",
"given": "Penghua"
},
{
"family": "Zhang",
"given": "Bohao"
},
{
"family": "Zhao",
"given": "Xin"
},
{
"family": "Zhang",
"given": "Xiaoan"
}
],
"container-title-short":
"volume": "17",
"page": "1837728",
"DOI": "10.3389/
"PMID": "42367795",
"PMCID": "PMC13303037",
"ISSN": "1664-3224",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
12
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s12974-025-03594-1
- Transcriptional and neuroprotective effects of hexokinase-2 inhibitors administered after stroke.Journal: Journal of neuroinflammationIn common: stroke, mouse, cellular / molecular, 7 references
- [2] doi:10.1016/j.jlr.2025.100776
- Hexokinase 2 promotes ISGylation of Acyl-CoA synthetase long-chain family member 4 in sepsis-induced microglia cells.Journal: Journal of lipid researchIn common: other condition, mouse, cellular / molecular, 5 references
- [3] doi:10.1111/jnc.16032
- Brain energy metabolism: A roadmap for future research.Journal: Journal of neurochemistryIn common: cellular / molecular, 4 references
- [4] doi:10.1186/s13024-026-00956-y [code]
- In vivo profiling of astrocyte secretome reveals brain-region specific regulatory networks in a mouse model of amyloid pathology.Journal: Molecular neurodegenerationIn common: mouse, cellular / molecular, 3 references
- [5] doi:10.1002/advs.202501894
- Glycolytic Enzyme HK2 Phosphorylates nSMase1 to Promote Astrocytic Exosomes Biogenesis Contributing to Acute Ischemic Stroke Injury.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: stroke, mouse, cellular / molecular, 2 references
- [6] doi:10.1002/advs.202519760
- ACSL1-Dependent Microglial Lipoimmunometabolic Reprogramming Underlies Cognitive Deficits in Alcohol Use Disorder.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: other condition, mouse, cellular / molecular, 2 references
- [7] doi:10.2147/ijn.s621038
- Protein Lactylation in Central Nervous System Diseases: Molecular Mechanisms and Targeted Therapeutic Strategies.Journal: International journal of nanomedicineIn common: cellular / molecular, 2 references
- [8] doi:10.3389/fped.2026.1891438
- Identification and clinical validation of F3 as a peripheral blood biomarker for neonatal hypoxic-ischemic encephalopathy using dataset-specific bioinformatics analysis.Journal: Frontiers in pediatricsIn common: other condition, 2 references
- [9] doi:10.1186/s13024-025-00887-0
- MS4A6A/
Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer's disease model. Journal: Molecular neurodegenerationIn common: mouse, cellular / molecular, 2 references - [10] doi:10.3389/fimmu.2025.1616312
- Identifying pyroptosis-hub genes and immune infiltration in neonatal hypoxic-ischemic brain injury.Journal: Frontiers in immunologyIn common: stroke, other condition, cellular / molecular, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
